Malaria drug could combat chemotherapy-resistant head and neck cancers
13.4% of high school students reported tobacco use in 2021
14 March 2022New type of vaccines could help against more respiratory illnesses
14 March 2022Malaria drug could combat chemotherapy-resistant head and neck cancers
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.
